Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07894822

Single-Session Microfocused Ultrasound, AbobotulinumtoxinA and Temporal Hyaluronic Acid Filler for Non-Surgical Brow Lifting

Sponsor: Estelab Clinic

View on ClinicalTrials.gov

Summary

This observational study describes the results of a routine aesthetic treatment for mild to moderate eyebrow drooping (brow ptosis). Thirty-six adults who came to Klinika Estelab (Moscow) asking for rejuvenation of the upper face received, as part of their usual care, one combined treatment session: microfocused ultrasound with visualization (Ultherapy), abobotulinumtoxinA (Dysport) injections, and hyaluronic acid filler in the temples, with a routine toxin touch-up after 2 weeks. The investigators did not assign any treatment; they only added standardized assessments. Eyebrow height was measured on standardized photographs before treatment, immediately after treatment, and at 1, 3, 6, and 12 months. Aesthetic improvement, patient satisfaction, procedural pain, and side effects were also recorded.

Official title: Single-Session Combination of Microfocused Ultrasound With Visualization, AbobotulinumtoxinA, and Temporal Hyaluronic Acid Filler for Non-Surgical Eyebrow Lifting: A Prospective Observational Cohort Study of Routine Clinical Practice

Key Details

Gender

All

Age Range

35 Years - 65 Years

Study Type

OBSERVATIONAL

Enrollment

36

Start Date

2024-01-01

Completion Date

2026-05-31

Last Updated

2026-10-26

Healthy Volunteers

No

Interventions

DEVICE

Microfocused ultrasound with visualization

Single session of microfocused ultrasound with visualization (Ultherapy, Merz Aesthetics) using the DS 10-1.5 transducer (10 MHz, 1.5 mm focal depth), performed as part of routine clinical care.

DRUG

AbobotulinumtoxinA

Intramuscular injections to the forehead, glabella, and lateral canthal area (total 100-200 Speywood units) in the same session, followed by a routine touch-up at 2 weeks, as part of routine clinical care.

DEVICE

Hyaluronic acid filler

Supraperiosteal injection into the temporal region with a needle after ultrasound vascular mapping, in the same session, as part of routine clinical care.

Locations (1)

Klinika Estelab LLC

Moscow, Moscow, Russia